首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1917796

居家輸液治療市場－2026-2031年預測

Home Infusion Therapy Market - Forecast from 2026 to 2031

出版日期: 2026年01月06日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計家庭輸液治療市場將從 2025 年的 294.5 億美元成長到 2031 年的 424.5 億美元，複合年成長率為 6.29%。

受醫療服務模式從醫療機構向患者家中轉移這一根本性轉變的推動，家庭輸液治療市場正經歷顯著且持續的成長。在這種模式下，包括抗生素、化療藥物、生物製藥、疼痛管理療法和營養支持在內的腸外給藥，均在居住監督下於患者家中進行。患者偏好、臨床療效、監管支持和技術進步等因素的強強聯合，推動了市場擴張，使家庭輸液治療成為以價值為導向的醫療保健策略的關鍵組成部分。

核心市場促進因素與臨床需求

推動居家醫療發展的關鍵因素在於其許多顯著優勢。研究一致表明，居家輸液治療的患者滿意度高，臨床療效良好，通常與住院治療的效果相當甚至更佳。從病人的觀點來看，居家治療提供了無與倫比的便利，既能維持日常生活規律並獲得家人支持，又能減輕頻繁就醫帶來的身心負擔。這與患者日益成長的意願相符，即在臨床條件允許的情況下，選擇在舒適且私密的家中接受治療。

從臨床角度來看，居家輸液治療是降低院內感染（HAI）風險的直接策略。透過縮短或淘汰住院時間，它可以減少患者接觸醫療機構中常見的耐多藥細菌和其他病原體的機會。這解決了急性照護中長期存在的挑戰，並為醫療服務提供者和支付者提供了重要的動力，促使他們更加關注病人安全指標的改善。

人口和流行病學趨勢進一步鞏固了這一需求。需要長期或反覆靜脈輸液治療的慢性疾病（例如自體免疫疾病和感染疾病）的日益普遍，造就了龐大的患者群體。同時，世界人口老化和行動不便疾病發生率的上升，使得患者前往診所就診的後勤挑戰更加突出。居家輸液治療直接解決了這些就醫障礙，確保了行動不便或受地理位置限制的患者能夠持續獲得治療。

監管和技術促進因素

支持性的法規結構和支付政策正在加速市場的正規化和擴張。主要市場近期對報銷結構的修訂擴大了福利範圍，不僅涵蓋輸液藥物，還包括相關的專業服務、護理以及居家安全用藥所需的遠端監測。這種經濟上的核准對於擴大服務範圍和鼓勵醫療服務提供者參與至關重要。

技術創新正在提升居家輸液的安全性、效率和覆蓋範圍。先進的互聯攜帶式輸液泵的研發，實現了精準給藥，並可遠端監測治療依從性和輸液泵功能。整合式數位化平台促進了藥劑師、護理師、處方醫生和患者之間的更緊密協作，簡化了複雜的流程，並改善了整個醫療服務鏈中的溝通。

市場挑戰與營運複雜性

儘管存在這些有利因素，但該市場仍面臨巨大的營運障礙。家庭輸液生態系統本身就十分複雜，需要多個相關人員之間的無縫協作，包括處方醫生、專科藥房、輸液護理服務機構、支付方以及患者本身。資料系統脫節和溝通管道分散會導致治療啟動延遲、計費錯誤以及潛在的安全隱患。在非受控的醫療機構環境下，實施嚴格的病患教育和維持有效的臨床監管仍然是至關重要的挑戰，需要結構化的通訊協定和技術支援。

此外，謹慎篩選患者對於成功實施至關重要。並非所有患者或治療方法必須包括臨床病情穩定、居家環境安全，以及患者或看護者管理自身照護的能力。滿足事先核准要求並向支付方證明成本效益，也是醫療服務提供者面臨的持續挑戰。

地理市場動態

北美是家庭輸液服務領域最成熟、最先進的地區，預計將繼續保持其市場主導地位。這一主導地位得益於有利的監管環境（積極擴大了報銷範圍）、慢性病高發、完善的專科藥房服務體係以及技術的廣泛應用。此外，眾多擁有專門輸液產品組合的成熟製藥和醫療設備公司的存在，進一步鞏固了該地區在推動創新和服務模式發展方面的核心地位。

競爭格局與策略展望

競爭格局由大型醫療保健公司、專業輸液藥局網路和醫院附屬醫療機構組成。主要參與者在臨床專長、地域覆蓋、支付方協議和技術整合方面展開競爭。策略重點領域包括開發綜合疾病管理方案、投資於用於病患監測的預測分析以及建立策略聯盟以創建能夠管理病人歷程的整合區域網路。

總之，家庭輸液治療市場正從小眾替代方案轉型為現代醫療保健服務的主流支柱。其成長主要得益於人口結構變化、促進診療點最佳化的經濟獎勵以及技術進步。對於業內專家而言，未來發展的關鍵在於規範護理通訊協定、推廣可互通的醫療資訊科技解決方案以降低生態系統的複雜性，以及持續累積可靠的真實世界證據，以證明該模式在患者療效、滿意度和整體醫療成本方面的卓越價值。預計未來的發展將由不斷拓展新的治療領域以及與更廣泛的居家照護計劃進行更深入的整合所驅動。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

介紹
北美洲
- 依產品類型
- 透過行政途徑
- 透過使用
- 按國家/地區
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 依產品類型
- 透過行政途徑
- 透過使用
- 按國家/地區
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 依產品類型
- 透過行政途徑
- 透過使用
- 按國家/地區
  - 德國
  - 法國
  - 英國
  - 西班牙
  - 其他
中東和非洲
- 依產品類型
- 透過行政途徑
- 透過使用
- 按國家/地區
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 以色列
  - 其他
亞太地區
- 依產品類型
- 透過行政途徑
- 透過使用
- 按國家/地區
  - 中國
  - 印度
  - 日本
  - 韓國
  - 印尼
  - 泰國
  - 台灣
  - 其他

第9章：競爭格局與分析

主要企業和策略分析
市佔率分析
企業合併、協議、商業合作
競爭對手儀錶板

第10章：公司簡介

B. Braun SE
Baxter International Inc.
Becton Dickinson Company
Fresenius Kabi
ICU Medical Inc.
Terumo Corporation
Nipro Corporation
KORU Medical Systems
CODAN Companies
BPL Medical Technologies

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要收益
分析方法
簡稱

簡介目錄

Product Code: KSI061615770

Home Infusion Therapy Market, with a 6.29% CAGR, is projected to increase from USD 29.450 billion in 2025 to USD 42.455 billion in 2031.

The home infusion therapy market is experiencing significant and sustained growth, driven by a fundamental shift in care delivery from institutional settings to the patient's home. This model involves the administration of parenteral medications, including antibiotics, chemotherapy, biologics, pain management therapies, and nutritional support, within a patient's residence under clinical supervision. The market's expansion is propelled by a powerful convergence of patient preference, clinical efficacy, regulatory support, and technological advancement, positioning home infusion as a critical component of value-based healthcare strategies.

Core Market Drivers and Clinical Imperatives

A primary driver is the compelling array of benefits associated with home-based care. Studies consistently demonstrate high levels of patient satisfaction and positive clinical outcomes with home infusion, often comparable or superior to inpatient settings. From a patient perspective, it offers unparalleled convenience, preserving normalcy and family support while eliminating the logistical and emotional burdens of frequent hospital visits. This aligns with a clear and growing patient preference for receiving care in the comfort and privacy of their own homes whenever clinically appropriate.

Clinically, home infusion presents a direct strategy for mitigating the risk of Hospital-Acquired Infections (HAIs). By reducing or eliminating inpatient stays, it lowers patient exposure to multi-drug resistant organisms and other pathogens prevalent in healthcare facilities. This addresses a persistent challenge in acute care and is a significant motivator for providers and payers focused on improving patient safety metrics.

Demographic and epidemiological trends further solidify demand. The growing prevalence of chronic conditions requiring long-term or recurring intravenous treatment-such as certain cancers, autoimmune disorders, and infections-creates a substantial patient base. Concurrently, an aging global population and the rising incidence of mobility-impairing disorders make the logistical challenges of accessing clinic-based care more pronounced. Home infusion directly addresses these access barriers, ensuring continuity of therapy for patients with physical or geographic constraints.

Regulatory and Technological Enablers

Supportive regulatory frameworks and payment policies are accelerating market formalization and expansion. Recent updates to reimbursement structures in key markets have broadened coverage to include not only the infused drugs but also the associated professional services, nursing care, and remote monitoring required for safe home administration. This financial validation is crucial for scaling service offerings and incentivizing provider participation.

Technological innovation is enhancing the safety, efficiency, and reach of home infusion. The development of advanced, connected ambulatory infusion pumps allows for precise drug delivery and remote monitoring of therapy adherence and pump function. Integrated digital platforms facilitate better coordination among pharmacists, nurses, prescribers, and patients, streamlining the complex workflow and improving communication across the care continuum.

Market Challenges and Operational Complexities

Despite strong tailwinds, the market faces notable operational hurdles. The home infusion ecosystem is inherently complex, requiring seamless coordination among multiple stakeholders: prescribing physicians, specialty pharmacies, infusion nursing services, payers, and the patients themselves. Disconnected data systems and fragmented communication channels can lead to delays in therapy initiation, billing inaccuracies, and potential safety gaps. Ensuring rigorous patient education and maintaining robust clinical oversight outside a controlled facility environment remain paramount concerns that demand structured protocols and technological support.

Furthermore, successful implementation depends on careful patient selection. Not all patients or therapies are suitable for the home setting; criteria must include clinical stability, a safe home environment, and the patient's or caregiver's ability to manage certain aspects of care. Navigating prior authorization requirements and demonstrating cost-effectiveness to payers also present ongoing administrative challenges for providers.

Geographic Market Dynamics

North America is projected to maintain a dominant market share, serving as the most mature and advanced region for home infusion services. This leadership is underpinned by a favorable regulatory landscape that has proactively expanded reimbursement, a high prevalence of chronic diseases, a well-developed infrastructure of specialty pharmacy providers, and significant technological adoption. The presence of established pharmaceutical and medical device companies with dedicated infusion portfolios further reinforces the region's central role in driving innovation and service models.

Competitive Landscape and Strategic Outlook

The competitive environment includes a mix of large healthcare corporations, specialized infusion pharmacy networks, and hospital-affiliated providers. Key players compete on the basis of clinical expertise, geographic coverage, payer contracts, and technological integration. Strategic focus areas include the development of comprehensive disease management programs, investment in predictive analytics for patient monitoring, and the formation of strategic alliances to create integrated regional networks capable of managing the full patient journey.

In conclusion, the home infusion therapy market is transitioning from a niche alternative to a mainstream pillar of modern healthcare delivery. Its growth is structurally supported by demographic shifts, economic incentives favoring site-of-care optimization, and technological enablement. For industry experts, the critical path forward involves standardizing care protocols, advancing interoperable health IT solutions to reduce ecosystem complexity, and continuing to generate robust real-world evidence demonstrating the model's superior value in terms of patient outcomes, satisfaction, and total cost of care. The trajectory points toward continued expansion into new therapeutic areas and deeper integration with broader home-based care initiatives.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Home Infusion Therapy Market Segmentation

By Product Type
Infusion Pumps
Infusion Catheters
Intravenous IV Sets
Others
By Route of Administration
Intravenous
Subcutaneous
By Application
Anti-Infective Therapy
Parenteral Nutrition
Chemotherapy
Pain Management Drugs
Hydration Therapy
Others
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. HOME INFUSION THERAPY MARKET BY PRODUCT TYPE

5.1. Introduction
5.2. Infusion Pumps
5.3. Infusion Catheters
5.4. Intravenous IV Sets
5.5. Others

6. HOME INFUSION THERAPY MARKET BY ROUTE OF ADMINISTRATION

6.1. Introduction
6.2. Intravenous
6.3. Subcutaneous

7. HOME INFUSION THERAPY MARKET BY APPLICATION

7.1. Introduction
7.2. Anti-Infective Therapy
7.3. Parenteral Nutrition
7.4. Chemotherapy
7.5. Pain Management Drugs
7.6. Hydration Therapy
7.7. Others

8. HOME INFUSION THERAPY MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Product Type
- 8.2.2. By Route of Administration
- 8.2.3. By Application
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Product Type
- 8.3.2. By Route of Administration
- 8.3.3. By Application
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Product Type
- 8.4.2. By Route of Administration
- 8.4.3. By Application
- 8.4.4. By Country
  - 8.4.4.1. Germany
  - 8.4.4.2. France
  - 8.4.4.3. United Kingdom
  - 8.4.4.4. Spain
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Product Type
- 8.5.2. By Route of Administration
- 8.5.3. By Application
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Israel
  - 8.5.4.4. Others
8.6. Asia Pacific
- 8.6.1. By Product Type
- 8.6.2. By Route of Administration
- 8.6.3. By Application
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. India
  - 8.6.4.3. Japan
  - 8.6.4.4. South Korea
  - 8.6.4.5. Indonesia
  - 8.6.4.6. Thailand
  - 8.6.4.7. Taiwan
  - 8.6.4.8. Others